New approaches for endorphin studies in psychiatry

References

• Beckman H, Saavedra J M, Wagner F G. Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics. Biological Psychiatry 1984; 19: 679–684
   Google Scholar
• Bergström L, Christensson I, Folkesson B, Stenstrom R, Terenius L. An ion exchange chromatography and radioimmunoassay procedure for measuring opioid peptides and substance P. Life Sciences 1983; 33: 1613–1619
   PubMed Web of Science ®Google Scholar
• Bloom F, Battenberg E, Rossier J, Ling N, Guillemin R. Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proceedings of the National Academy of Science USA 1978; 75: 1591–1595
   PubMed Web of Science ®Google Scholar
• Chen C-L, Mather J P, Morris P L, Bardin C W. Expression of pro-opiomelanocortin-like gene in the testis and epididymis. Proceedings of the National Academy of Science USA 1984; 81: 5672–5675
   PubMed Web of Science ®Google Scholar
• Domschke W, Dickschas A, Mitznegg P. CSF beta-endorphin in schizophrenia. Lancet 1979; 1: 1024
   Google Scholar
• Gubler U, Seeburg P, Hoffman B JG, Age L P, Uden-Friend S. Molecular cloning established proenk-ephalin as precursor of enkephalin-containing peptides. Nature 1982; 295: 510–526
   Google Scholar
• Gunne L-M, Lindström L, Terenius L. Nalox-one-induced reversal of schizophrenic hallucinations. Journal of Neural Transmission 1977; 40: 13–19
   PubMed Web of Science ®Google Scholar
• Kakidani H, Furutani Y, Takahashi H, Noda M, Mori-Moto Y, Hirose T, Asai M, Inayama S, Nakanishi S, Numa S. Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature 1982; 298: 245–249
   PubMed Web of Science ®Google Scholar
• Kety S S. The syndrome of schizophrenia: Unresolved questions and opportunities for research. British Journal of Psychiatry 1980; 136: 421–436
   PubMed Web of Science ®Google Scholar
• Kleine T O, Klempel K, Funfgeld E W (1984) Methionine-(Met)-enkephalin and leucine-(Leu)-en-kephalin in CSF of chronic schizophrenics: correlation with psychopathology. Protides of the Biological Fluids. Proceedings of the 32nd Colloquium. 1984, H Peeters. Pergamon Press, New York
   Google Scholar
• Kosterlitz H W, Paterson S J, Robson L E. Opioid peptides and their receptors. Neuropeptides: Basic and Clinical Aspects, G Flink, L J Whalley. Churchill Livingstone, Edinburgh 1983; 3–11
   Google Scholar
• Lindström L H, Widerlöv E, Gunne L-M, Wahlström A, Terenius L. Endorphins in human cerebrospinal fluid: Clinical correlation to some psychotic states. Acta psychiatrica Scandinavica 1978; 57: 153–164
   PubMed Web of Science ®Google Scholar
• Lindström L H, Besev G, Gunne L-M, Sjöström R, Terenius L, Wahlström A, Wistedt B. Cerebrospinal fluid content of endorphins in schizophrenia. Endorphins and Opiate Antagonists in Psychiatric Research, N S Shah, A G Donald. Plenum, New York 1982; 245–256
   Google Scholar
• Lo C W, Wen H L, Ho W KK. Cerebrospinal fluid (Met5) enkephalin level in schizophrenics during treatment with naloxone. European Journal of Pharmacology 1983; 92: 77–81
   Google Scholar
• Maniatis T, Fritsch E F, Sambrook J. Molecular cloning: A Laboratory Manual. Cold Spring Harbor, New York 1982
   Google Scholar
• Maysinger D, Hollt V, Seizinger B R, Mehraein P, Pasi A, Herz A. Parallel distribution of immunoreac-tive alpha-neo-endorphin and dynorphin in rat and human tissue. Neuropeptides 1982; 2: 211–225
   Web of Science ®Google Scholar
• Nakanishi S, Inoue A, Kita T, Nakamura M, Chang A CY, Cohen S N, Numa S. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipo-tropin precursor. Nature 1979; 278: 423–427
   PubMed Web of Science ®Google Scholar
• Nakao K, Oki S, Tanaka I, Horii K, Nakai Y, Furui T, Fukushima M, Kuwayama A, Kageyama N, Imura H. Immunoreactive beta-endorphin and adrenocorticotropin in human cerebrospinal fluid. Journal of Clinical Investigation 1980; 66: 1383–1390
   Google Scholar
• Nyberg F, Terenius L. Endorphins in human cerebrospinal fluid. Life Sciences 1982; 31: 1737–1740
   PubMedGoogle Scholar
• Nyberg F, Wahlström A, Sjölund B, Terenius L. Characterization of electrophoretically separable endorphins in human CSF. Brain Research 1983; 259: 267–274
   PubMed Web of Science ®Google Scholar
• Nyberg F, Terenius L. Identification of high molecular weight enkephalin precursor forms in human cerebrospinal fluid. Neuropeptides 1985; 5: 537–540
   Google Scholar
• Nyberg F, Le Greves P, Sundqvist C, Terenius L. Characterization of substance P (1–7) and (1–8) generating enzyme in human cerebrospinal fluid. Biochemical and Biophysical Research Communications 1984; 125: 244–250
   PubMed Web of Science ®Google Scholar
• Pickar D, Cohen M R, Naber D, Cohen R M. Clinical studies of the endogenous opioid system. Biological Psychiatry 1982; 17: 1243–1276
   PubMed Web of Science ®Google Scholar
• Pope A, Nixon R A. Proteases of human brain. Neurochemical Research 1984; 9: 291–323
   PubMed Web of Science ®Google Scholar
• Rimon R, Terenius L, Kampman R. Cerebrospinal fluid endorphins in schizophrenia. Acta Psychiatrica Scandinavica 1980; 61: 395–403
   Google Scholar
• Sabol S L, Yoshikawa K, Hong J-S. Regulation of methionine-enkephalin precursor messenger RNA in rat striatum by haloperidol and lithium. Biochemical and Biophysical Research Communications 1983; 113: 391–399
   Google Scholar
• Sadee W, Richards M L, Grevel J, Rosenbaum J S. Multiple opioid binding sites in vivo: Drug occupancy and pharmacological effect. Life Sciences 33 Supplement 1983; 1: 187–189
   Google Scholar
• Schwartz J P, De La Baume S, Llorens C, Malfroy B, Soroca E, Fournie-Zaluski M C, Roques B P, Mor-Gat J L, Roy J, Javoy-Agid F, Agid Y. Enkephalin dipeptidyl carboxypeptidase («Enkephalinase»): Assay properties and distribution in human brain and exploration of the active site. Advances in Biochemical Psychopharmacology 1982; 33: 225–234
   Google Scholar
• Schweidfurth H, Schioberg-Schiegnitz S. Assay and biochemical characterization of angiotensin I converting enzyme in cerebrospinal fluid. Enzyme 1984; 32: 12–19
   Google Scholar
• Tang F, Costa E, Schwartz J P. Increase of pro-enkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proceedings of the National Academy of Science USA 1983; 80: 3841–3844
   PubMed Web of Science ®Google Scholar
• Terenius L, Wahlström A, Lindström L, Widerlöv E. Increased CSF levels of endorphins in chronic psychosis. Neuroscience Letters 1976; 3: 157–162
   PubMed Web of Science ®Google Scholar
• Terenius L, Nyberg F. Clinical significance of neuropeptide measurements in body fluids. Proceedings of the Second International Congress in Clinical Pharmacology, Washington, D.C., 1983; 733–744
   Google Scholar
• Watson S, Akil H, Ghazarossian V E, Goldstein A. Dynorphin immunocytochemical localization in brain and peripheral nervous system: Preliminary studies. Proceedings of the National Academy of Science USA 1981; 78: 1260–1263
   Google Scholar
• Watson S, Akil H, Fischli W, Goldstein A, Zimmerman E, Nilaver G, Wimersma-Greidanus T B. Dynorphin and Vasopressin;common localization in magnocellular neurons. Science 1982; 216: 85–87
   PubMed Web of Science ®Google Scholar
• Watson S, Albala E, Berger E, Akil H. Peptides in Psychiatry. Brain Peptides, D Kreeger, M J Brownstein, J Martin. Wiley, New York 1983; 351–368
   Google Scholar
• Yokosawa H, Ogura Y, Ishii S. Purification and inhibition by neuropeptides of angiotensin-convert-ing enzyme from rat brain. Journal of Neurochemis-try 1983; 41: 403–410
   Google Scholar